Hennessy Capital Investment Corp VI (NASDAQ:HCVI) announced in an 8-K filing this morning that it will push its September 27 extension vote to 9 am ET September 29.
Shareholders will now have until 5 pm ET September 27 to make their final redemption decisions and owners of 132,398 shares have decided to stay in as a part of a non-redemption agreement Hennessy VI also announced in the filing.
This third party investor will receive 9,735 promote shares in exchange for this commitment. The SPAC has not yet announced a definitive agreement and is seeking to extend its deadline to January 10, 2024 without contributing additional funds to its trust.
The Hennessy team has taken over both two (NYSE:TWOA) and Compass Digital (NASDAQ:CDAQ) in transactions for their existing sponsor economics this year, but Hennessy VI is a vehicle that the group launched on their own in 2021.
This SPAC is seeking to combine with a target valued at over $1 billion with a large addressable market and strong management.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...